- This event has passed.
Webinar: How Companies Approach Academic Research Engagement in these Disruptive Times
April 22 @ 11:00 am - 12:00 pm
Join us to learn how our industry members, in diverse sectors, are evaluating and reframing their current approaches to academic collaborations.
The COVID-19 pandemic is having a profound impact on our lives and on our economy. Universities and colleges are virtual, companies are curbing operations. Supply chains are pivoting to support food, medical, and household goods distribution, and social distancing has become normalized. At the same time, the research community has shifted into high gear to develop solutions to this major challenge. Learn how our industry members, in diverse sectors, are evaluating and reframing their current approaches to academic collaborations.
Free for members, registration required.
Who Should Attend
- Leaders in academic and corporate organizations, as well as other interested parties who are dedicated to forming partnerships to lead their groups to advance research in the current environment.
The webinar will focus primarily on:
- evaluating (or reevaluating) the value of U-I partnerships and collaborations;
industry perspectives and opportunities with academic research; and
- industry strategies to partner with academics to create innovation.
We’ll also explore:
- How companies can honor current commitments to research projects, and whether there will be receptivity to flexibility in revising project timelines;
- How new academic collaborations can move forward, and if so, whether they will be business-as-usual or will refocus on COVID-19-related research and topics;
- How constrained budgets will present new opportunities for multi-company projects.
- This highly participatory webinar includes presentations, interactive discussion, and Q&A.
Maxine Allen, director of industry partnerships at University of Oxford Medical Sciences Division. She promotes and supports industry engagement with the biomedical science departments at the University of Oxford and the Oxford University Hospitals through strategic alliances, R&D collaborations, contract and clinical research, and resource sharing. She previously worked for biotech companies in the US and UK.
Malcolm Skingle, director, academic liaison at GlaxoSmithKline. Malcolm has bachelor’s degree in pharmacology/biochemistry and doctorate in neuropharmacology. He has worked in the pharmaceutical industry his entire career, was formerly a neuropharmacologist and has over 60 publications including articles on the interface between industry and academia.
Jennifer Moe, open innovation manager at Procter & Gamble. Her primary focus is on accelerating innovation through external partnerships that include academia. Jenny has spent the majority of her 26-year career developing products for the fabric care category. She led alliance programs for the company with both the appliance industry in the US and strategic chemical suppliers. She holds a doctorate in organometallic chemistry from the UNC Chapel Hill.
Rob Matles, managing director, JPMorgan Chase. Rob advances firm-wide innovation strategy and oversees the intellectual property portfolio, including more than 1,100 patents. He is also responsible for the Future Lab for Applied Research and Engineering (FLARE) program, managing research in emerging technologies like quantum computing, service mesh, and virtual reality. He previously served as a captain in the US Air Force and a senior manager at Accenture.